Advertisement
News
Advertisement

Cellceutix says Kevetrin may work on brain tumor

Wed, 05/30/2012 - 11:34am
Mass High Tech: The Journal of New England Technology

Cellceutix Corp. (OTCBB: CTIX) in Beverly announced Wednesday that it has research showing that its compound, Kevetrin, which is being developed to fight several drug-resistant cancers, may also be effective against brain tumors.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading